1. Market Research
  2. > Biotechnology Market Trends
  3. > Analyzing the Biotechnology Industry in India

Analyzing the Biotechnology Industry in India

  • February 2014
  • -
  • Aruvian's R'search
  • -
  • 145 pages

The Indian biotechnology sector is one of the most aggressively growing industries in the Asia Pacific region. A liberalized intellectual property regime and multinational companies investing heavily in the country's biotech industry, the Indian biotechnology market has witnessed remarkable growth in recent years. The biotech industry in India did not bear the brunt of the recent economic recession and in fact due to the global financial crisis, many multinational companies actually shifted their R&D pipelines to the lower cost Indian market.

Aruvian Research analyzes the Indian biotechnology market in its research report Analyzing the Biotechnology Industry in India. The report begins with an overview of the global biotechnology industry through an industry definition, industry overview, performance and value analysis of the industry, industry segmentation and a future perspective of the global biotechnology industry. A Porter's Five Forces Framework Analysis of the global biotechnology industry is also included in the report.

An analysis of the biotechnology industry in Asia Pacific is conducted through an industry overview, industry value analysis, industry segmentation and an outlook for the market. Moving on to the analysis of the biotechnology industry in India, we analyze the market through an industry overview, the impact of the economic recession on the market, investment in the market, major biotech companies and their major tie-ups, stem cell research and the emerging market for biosimilars in India.

A Porter's five forces analysis on the Indian biotechnology market is also included, followed by an analysis of the major industry segments such as bioagriculture, bioindustry, bioinformatics, biopharmaceuticals and bioservices.

Regulatory framework governing the Indian biotechnology industry is looked at along with an analysis of government and state-level initiatives.

Emerging business models and industry trends are also analyzed followed by an analysis of the major players in the Indian biotechnology market.

Table Of Contents

Analyzing the Biotechnology Industry in India
A. Executive Summary

B. Global Biotechnology Industry
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Performance
B.4 Industry Value
B.5 Industry Segmentation
B.6 Global Biotechnology Market: Future Perspective

C. Global Biotechnology Industry: Porter's Five Forces Framework Analysis
C.1 Introduction
C.2 Bargaining Power of Buyer
C.3 Bargaining Power of Suppliers
C.4 Competitive Rivalry in the Industry
C.5 Threat of New Entrants
C.6 Threat of Industry Substitution

D. Asia Pacific Biotechnology Industry
D.1 Industry Overview
D.2 Industry Value
D.3 Industry Segmentation
D.4 Asia Pacific Biotechnology Market: Future Perspective

E. Biotechnology Market in India
E.1 Industry Overview
E.2 Impact of the Economic Recession
E.3 Investment in India's Biotechnology Market
E.4 Investment in Research and Infrastructure
E.5 Biotech Companies in India
E.6 Major Tie-ups
E.7 Stem Cell Research
E.8 Market for Biosimilars in India

F. India Biotechnology Market: Porter's Five Forces Framework Analysis
F.1 Buyers'/Customers' Power
F.2 Suppliers' Power
F.3 Rivalry among Competitors
F.4 Threat of New Entrants
F.5 Threat of Substitutes

G. Analysis of Major Segments
G.1 BioAgriculture
G.1.1 Hybrid Seeds
G.1.2 Biopesticides and Biofertilizers
G.2 BioIndustrial
G.3 BioInformatics
G.4 Biopharmaceuticals
G.5 Bioservices

H. Regulatory Framework
H.1 Overview
H.2 Government Initiatives
H.3 State-level Initiatives
H.3.1 Andhra Pradesh
H.3.2 Tamil Nadu
H.3.3 Maharashtra
H.3.4 Karnataka
H.3.5 Himachal Pradesh
H.4 Intellectual Property Regime and the Biotech Industry

I. Emerging Business Models and Industry Trends
I.1 Business Models
I.2 Public-Private Partnerships
I.3 Lack of Venture Capital Funding
I.4 Moving up the Value Chain
I.5 Enhancing Biotech Applications
I.6 Domestic Biotech Market Posts Robust Growth
I.7 Skilled Manpower
I.8 Shortage of Manpower
I.9 Convergence of Pharma and Biotech
I.10 Boosting North-South Collaborations
I.11 Innovation in Funding Models
I.12 Cluster Development

J. Generics in the Indian Biotech Industry

K. Emergence of Biogenerics in India
K.1 Introduction
K.2 Biologics Manufacturing in India
K.3 Opportunities in the Market
K.4 Challenges Facing the Industry
K.5 Regulatory Issues
K.6 Market Outlook

L. Major Industry Players
L.1 Aurobindo Pharma Limited
L.2 Bharat Biotech
L.3 Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL)
L.4 Biocon Limited
L.5 Dr. Reddy's Laboratories
L.6 GlaxoSmithKline Pharmaceuticals Limited
L.7 Indian Immunologicals Ltd
L.8 Jubilant Life Sciences Limited
L.9 Krebs Biochemicals and Industries Ltd
L.10 Morepen Laboratories
L.11 Piramal Enterprises
L.12 Quintiles Transnational Corporation
L.13 Ranbaxy Laboratories (acquired by Daiichi Sankyo)
L.14 Rasi Seeds
L.15 Reliance Life Sciences
L.16 Serum Institute of India
L.17 Shantha Biotechnics (Part of Sanofi-Aventis Group)
L.18 Stempeutics Research
L.19 Sun Pharma Advanced Research Company
L.20 Venkateshwara Hatcheries Private Limited
L.21 Wockhardt Limited
L.22 Novo Nordisk
L.22.1 Corporate Profile
L.22.2 Business Segment Analysis
L.22.3 SWOT Analysis
L.23 Panacea Biotec
L.23.1 Corporate Profile
L.23.2 Business Segment Analysis
L.23.3 SWOT Analysis

M. Future of the Indian Biotechnology Market
M.1 Market Outlook
M.2 Opportunities in the Sector



List of Figures

Figure 1: Regional Share of Global Biotechnology Revenues (%), 2012
Figure 2: Value of the Global Biotechnology Industry (in USD Billion), 2008-2012
Figure 3: Global Biotechnology Industry Segmentation (%), 2012
Figure 4: Geographic Segmentation of the Global Biotechnology Industry (%), 2012
Figure 5: Forecast of the Global Biotechnology Industry (in USD Billion), 2012-2017
Figure 6: Porter's Five Forces Analysis of the Global Biotechnology Industry
Figure 7: Value of the Asia Pacific Biotechnology Industry (in USD Billion), 2008-2012
Figure 8: Asia Pacific Biotechnology Industry Segmentation (%), 2012
Figure 9: Geographic Segmentation of the Asia Pacific Biotechnology Industry (%), 2012
Figure 10: Asia Pacific Biotechnology Industry (in USD Billion), 2012-2017
Figure 11: Biotechnology Cluster Growth in India, 2006-2012
Figure 12: Major Biotech Research Centers in India
Figure 13: Emerging New Business Models
Figure 14: Advantages in R and D Sourcing



List of Tables

Table 1: Value of the Global Biotechnology Industry (in USD Billion), 2008-2012
Table 2: Global Biotechnology Industry Segmentation (in USD Billion and %), 2012
Table 3: Geographic Segmentation of the Global Biotechnology Industry (in USD Billion and %), 2012
Table 4: Forecast of the Global Biotechnology Industry (in USD Billion), 2012-2017
Table 5: Value of the Asia Pacific Biotechnology Industry (in USD Billion), 2008-2012
Table 6: Asia Pacific Biotechnology Industry Segmentation (in USD Billion and %), 2012
Table 7: Geographic Segmentation of the Asia Pacific Biotechnology Industry (in USD Billion and %), 2012
Table 8: Asia Pacific Biotechnology Industry (in USD Billion), 2012-2017
Table 9: Segment-wise Turnover of the Indian Biotech Industry




Companies Mentioned

Aurobindo Pharma Limited
Bharat Biotech
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL)
Biocon Limited
Dr. Reddy's Laboratories
GlaxoSmithKline Pharmaceuticals Limited
Indian Immunologicals Ltd
Jubilant Life Sciences Limited
Krebs Biochemicals and Industries Ltd
Morepen Laboratories
Novo Nordisk
Panacea Biotec
Piramal Enterprises
Quintiles Transnational Corporation
Ranbaxy Laboratories
Rasi Seeds
Reliance Life Sciences
Serum Institute of India
Shantha Biotechnics
Stempeutics Research
Sun Pharma Advanced Research Company
Venkateshwara Hatcheries Private Limited
Wockhardt Limited

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021. Over the years, ...

Humanized Mouse Model Market by Type, Application & End User - Global Forecast to 2021

Humanized Mouse Model Market by Type, Application & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021). Growing adoption of personalized ...

Rat Model Market by Model Type, Technology, Therapeutic Area, Service, Care Products & End User -Global Forecast to 2021

Rat Model Market by Model Type, Technology, Therapeutic Area, Service, Care Products & End User -Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The rat model market is projected to reach USD 588.9 million by 2021 from USD 387.7 million in 2016, growing at a CAGR of 8.7% during the forecast period. Continuous support in the form of investments ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.